BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27065718)

  • 21. Four cases of pseudomyxoma peritonei with ovarian tumors at our hospital.
    Yazawa R; Yazawa H; Fukuda K; Ohara M; Osuka F
    Fukushima J Med Sci; 2023 Apr; 69(1):57-65. PubMed ID: 36990788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms.
    Abudeeb H; Selvasekar CR; O'Dwyer ST; Chakrabarty B; Malcolmson L; Renehan AG; Wilson MS; Aziz O
    Surg Endosc; 2020 Dec; 34(12):5516-5521. PubMed ID: 31993814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei.
    Govaerts K; Chandrakumaran K; Carr NJ; Cecil TD; Dayal S; Mohamed F; Thrower A; Moran BJ
    Eur J Surg Oncol; 2018 Sep; 44(9):1371-1377. PubMed ID: 30017331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
    Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
    Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei.
    Lamps LW; Gray GF; Dilday BR; Washington MK
    Mod Pathol; 2000 May; 13(5):495-501. PubMed ID: 10824920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
    Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
    Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review.
    Ning S; Yang Y; Wang C; Luo F
    BMC Surg; 2019 Apr; 19(1):42. PubMed ID: 31023277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review.
    Martín-Román L; Hannan E; Faraz Khan M; Müller AS; Shields C; Aird J; Moran B; Mulsow J
    Pleura Peritoneum; 2023 Jun; 8(2):65-74. PubMed ID: 37304162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucinous neoplasms of the appendix and peritoneum.
    Panarelli NC; Yantiss RK
    Arch Pathol Lab Med; 2011 Oct; 135(10):1261-8. PubMed ID: 21970481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology.
    Memon AA; Godbole C; Cecil T; Dayal S; Moran B; Tzivanakis A; Mohamed F; Carr NJ
    Ann Surg Oncol; 2022 Apr; 29(4):2607-2613. PubMed ID: 34731401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms.
    Young RH
    Semin Diagn Pathol; 2004 May; 21(2):134-50. PubMed ID: 15807473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
    Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
    Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience.
    Santullo F; Pacelli F; Abatini C; Attalla El Halabieh M; Fortunato G; Lodoli C; Giovinazzo F; Rotolo S; Di Giorgio A
    Front Surg; 2021; 8():715119. PubMed ID: 34513915
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Yoshizaki Y; Gohda Y; Inagaki F; Kataoka A; Takemura N; Miyazaki H; Igari T; Kiyomatsu T; Yano H; Kokudo N
    Clin J Gastroenterol; 2024 Feb; 17(1):188-197. PubMed ID: 37980306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei.
    Buell-Gutbrod R; Gwin K
    Am Soc Clin Oncol Educ Book; 2013; ():221-5. PubMed ID: 23714507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of bromelain and acetylcysteine in pseudomyxoma peritonei (PMP) caused by low-grade appendiceal mucinous neoplasm (LAMN): a case report.
    Geisel D; Langen U; Rüdiger T
    J Med Case Rep; 2023 Jun; 17(1):297. PubMed ID: 37381056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?
    Huang Y; Alzahrani NA; Liauw W; Traiki TB; Morris DL
    Ann Surg Oncol; 2017 Jan; 24(1):176-183. PubMed ID: 27718032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin.
    Chandrakumaran K; Carr NJ; Mohamed F; Cecil TD; Moran BJ
    JAMA Surg; 2023 May; 158(5):522-530. PubMed ID: 36920381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.